| 标题 |
 WED-371 Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Hepatology 作者：Man-Fung Yuen; Jeong Heo; Ronald G. Nahass; G. Wong; Tatiana Burda; et al 出版日期：2024-06-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
无极微光
啦啦
v0id
小年糕
kaio_escolar
invisight
庄园在逃害人精
DW
极限001
乐空思
电池狗做实验
秦艽
初景
Elsevier大王
牧青
地球合适爆炸
贪玩的秋柔
舒服的楷瑞
AireenBeryl531
皖公网安备34019202002308
